John M. Limongelli

John M. Limongelli joined Imvax as Chief Legal Officer in September 2021 bringing with him nearly 25 years of legal experience in the life sciences industry. He previously served as Senior Vice President, General Counsel, and Corporate Secretary at Neos Therapeutics, a publicly-traded biotechnology company, and Senior Vice President, General Counsel, and Chief Administrative Officer at Trevena (NASDAQ: TRVN). Mr. Limongelli has also held high-level legal roles at Cigna Corporation (NYSE: CI) as Corporate Secretary; at Adolor, a publicly-traded biotechnology company, as Senior Vice President, General Counsel, and Secretary; and at Cephalon, a publicly-traded biotechnology company, as Vice President, Associate General Counsel, and Secretary. He began his legal career in private practice with Morgan, Lewis & Bockius, LLP, and previously was a Certified Public Accountant with KPMG LLP.

Mr. Limongelli obtained both his J.D. and MBA from Temple University.